About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

SMARTHEART Validation Study | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT04755582

SMARTHEART Validation Study

To compare the accuracy of novel smartphone or wearable ECG devices to a gold standard ECG in patients with normal and abnormal ECGs.

Lead sponsor: University of Leicester•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Zakariyya Vali

CONTACT

01162502366 [email protected]

Sponsors

Lead Sponsor

University of Leicester

Assess the effect of the following on the accuracy of the recorded ECG compared to a gold standard ECG: * Posture or position of the patient * Movement * Amount of hair on the ECG site * Skin condition (tone/dryness) Ability to detect a paced rhythm accurately A qualitative assessment of ECG devices, including the amount of artefact in the signal and ease of use of the device

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Participant is willing and able to give informed consent for participation in the study.
•Must have an adequate understanding of written and spoken English
•Able (in the Investigators opinion) and willing to comply with study requirements.
•Must be over 18 years of age
•Must be deemed clinically stable by their direct care team.

Exclusion Criteria

•Subjects who do not have an adequate understanding of written and spoken English
•Patients who are medically unstable, as defined by the patient's direct care team.
•Patients who are unable to give informed consent
•Patients who are deemed clinically unstable by their direct care team

Related studies

Health Ahead Comparative Effectiveness Study

NCT07669168 · Health Services Accessibility, Rural Health, and more

Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry

NCT07256249 · Cardiovascular Diseases

RECRUITINGPhase 3

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

NCT07613294 · Atherosclerosis, Cardiovascular Diseases, and more

RECRUITINGPhase 4

Treatment With Aspirin After Preeclampsia: TAP Trial

NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more

Developing a Brief Intervention to Communicate Cardiovascular Risk to Patients Presenting to the Emergency Department With Chest Pain: a Co-Production Approach. Phase 2.

NCT06903442 · Cardiovascular Diseases

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 16, 2021Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment128

Start dateJul 2021

Last updatedFeb 16, 2021

Condition

Cardiovascular Diseases

Locations shown

Glenfield Hospital, University Hospitals of Leicester NHS Trust

Leicester, Leicestershire

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 16, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions